New and emerging therapies for women, girls, and people with the potential to menstruate with VWD.
Journal Information
Full Title: Blood Adv
Abbreviation: Blood Adv
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict-of-interest disclosure: C.C. is coinventor on a patent regarding KB-V13A12. J.L. has received honoraria payments from CSL Behring. P.D.J. receives research funding from 10.13039/100004326Bayer and consultancy fees from Band/Guardian Therapeutics, Star/Vega Therapeutics, BioMarin, and Roche."
Funding Disclosure
Evidence found in paper:
"10.13039/100004326Bayer"
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025